SCHEMBL14723183

SCHEMBL14723183

O=C(O)N(C1CCNCC1)C1CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA5 P31644 4/20 0.46
GABRA1 P14867 3/20 0.46
GABRB2 P47870 3/20 0.46
TSHR P16473 2/20 0.46
GABRG2 P18507 2/20 0.46
GABRB3 P28472 2/20 0.46
GABRA3 P34903 2/20 0.46
GABRA2 P47869 2/20 0.46
GABRA6 Q16445 2/20 0.46
GABRA4 P48169 2/20 0.46
GABRP O00591 1/20 0.46
GABRD O14764 1/20 0.46
GABRB1 P18505 1/20 0.46
GABRE P78334 1/20 0.46
PMP22 Q01453 1/20 0.46
GABRG1 Q8N1C3 1/20 0.46
GABRG3 Q99928 1/20 0.46
GABRQ Q9UN88 1/20 0.46
SLC6A4 P31645 2/20 0.39
EPHX1 P07099 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16795227 0.91 SLC6A4 (0.44) GABRA5GABRA1GABRB2TSHRGABRG2
SCHEMBL27905533 0.89 SLC6A2 (0.43) GABRA5GABRA1GABRB2TSHRGABRG2
SCHEMBL27905543 0.89 SLC6A2 (0.43) GABRA5GABRA1GABRB2TSHRGABRG2
SCHEMBL5023299 0.89 SLC6A2 (0.43) GABRA5GABRA1GABRB2TSHRGABRG2
SCHEMBL25306928 0.83 SLC6A4 (0.49) GABRA5GABRB2TSHRSLC6A4LMNA
SCHEMBL4167603 0.83 SLC6A4 (0.49) GABRA5GABRB2TSHRSLC6A4LMNA
SCHEMBL4594933 0.81 SLC6A1 (0.35) GABRA5GABRA1GABRB2TSHRGABRG2
SCHEMBL296408 0.79 GABRA1 (0.39) GABRA5GABRA1GABRB2TSHRGABRG2
Hydrochloric Acid SCHEMBL3746410 0.77 GABRA1 (0.38) GABRA5GABRA1GABRB2TSHRGABRG2
SCHEMBL17699940 0.77 SLC6A1 (0.47) TSHRSLC6A4CPN1CPB2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013026587-A1 1,4 DISUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2013-02-28 WO disclosed